Axa
ARRY

Axa’s Array Biopharma Inc ARRY Stock Holding History

Axa’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-124,920
Closed -$5.79M – 1393
2019
Q2 		$5.79M Sell
124,920
-144,332
-54% -$4.05M 0.02% 604
2019
Q1 		$6.56M Sell
269,252
-192,234
-42% -$4M 0.03% 564
2018
Q4 		$6.58M Hold
461,486
– – 0.03% 535
2018
Q3 		$7.01M Hold
461,486
– – 0.03% 571
2018
Q2 		$7.74M Sell
461,486
-118,187
-20% -$1.88M 0.03% 530
2018
Q1 		$9.46M Buy
579,673
+209,028
+56% +$3.35M 0.04% 461
2017
Q4 		$4.74M Sell
370,645
-80,986
-18% -$921K 0.02% 666
2017
Q3 		$5.55M Sell
451,631
-337,624
-43% -$3.14M 0.02% 597
2017
Q2 		$6.61M Buy
789,255
+133,481
+20% +$1.09M 0.03% 533
2017
Q1 		$5.86M Sell
655,774
-224,449
-25% -$2.39M 0.03% 566
2016
Q4 		$7.74M Buy
880,223
+16,549
+2% +$122K 0.04% 471
2016
Q3 		$5.83M Sell
863,674
-821,998
-49% -$3.18M 0.03% 534
2016
Q2 		$6M Sell
1,685,672
-69,101
-4% -$225K 0.03% 525
2016
Q1 		$5.18M Sell
1,754,773
-28,350
-2% -$84.9K 0.02% 561
2015
Q4 		$7.53M Buy
1,783,123
+882,626
+98% +$4.03M 0.03% 454
2015
Q3 		$4.11M Sell
900,497
-19,050
-2% -$113K 0.02% 620
2015
Q2 		$6.63M Hold
919,547
– – 0.03% 512
2015
Q1 		$6.78M Buy
919,547
+64,941
+8% +$462K 0.03% 499
2014
Q4 		$4.04M Buy
+854,606
New +$3.38M 0.02% 614

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Axa's ARRY Position: Q3 2019 in Review

Axa sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 124,920 shares — an estimated $5.79M sold.

Axa first reported a position in ARRY in Q4 2014 and held it in 19 quarters. The position peaked at $9.46M in Q1 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Axa reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Axa sold 124,920 Array Biopharma Inc shares in Q3 2019, an estimated $5.79M.
  • Axa first reported a position in Array Biopharma Inc in Q4 2014 and held it in 19 quarters.
  • Axa's Array Biopharma Inc position peaked at $9.46M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Axa's 13F filing for Q3 2019, filed 14 Nov 2019.